Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matías Muñoz-Medel

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Asian Pacific Journal of Cancer Prevention : APJCP|January 26, 2019
Prevalence of EGFR Mutations and Clinico-Pathological Characteristics of Chilean Lung Cancer PatientsRoger Gejman, Sergio González, Matías Muñoz-Medel, et al.
Frontiers in Oncology|May 29, 2024
<i>Porphyromonas gingivalis</i>, a bridge between oral health and immune evasion in gastric cancerMatías Muñoz-Medel, Mauricio P Pinto, Lauren Goralsky, et al.
International Journal of Molecular Sciences|December 16, 2020
The Reprimo-Like Gene Is an Epigenetic-Mediated Tumor Suppressor and a Candidate Biomarker for the Non-Invasive Detection of Gastric CancerMaría Alejandra Alarcón, Wilda Olivares, Miguel Córdova-Delgado, et al.
BJR Case Reports|April 4, 2025
Isocitrate dehydrogenase 1 gene mutations: a case review unveiling its biological impact on disease progression, prognosis and treatment in Chilean patientsTomás de Mayo Glasser, Benjamín García-Bloj, Juan A Godoy, et al.
Revista Medica De Chile|November 9, 2021
[Update on neuroendocrine tumors]Diego Carrillo, Matías Muñoz-Medel, Ignacio Retamal, et al.
International Journal of Molecular Sciences|January 8, 2023
Differentially Expressed Genes and Signaling Pathways Potentially Involved in Primary Resistance to Chemo-Immunotherapy in Advanced-Stage Gastric Cancer PatientsMauricio P Pinto, Matías Muñoz-Medel, Ignacio N Retamal, et al.
BMC Cancer|September 16, 2021
A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancerMiguel Cordova-Delgado, María Loreto Bravo, Elisa Cumsille, et al.
JCO Global Oncology|April 24, 2020
Retrospective Analysis of Chilean and Mexican GI Stromal Tumor Registries: A Tale of Two Latin American RealitiesGermán Calderillo, Matías Muñoz-Medel, Edelmira Carbajal, et al.
Cancers|July 16, 2020
A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical ApplicabilityMauricio P Pinto, Miguel Córdova-Delgado, Ignacio N Retamal, et al.
Oncology Reports|June 20, 2025
Comprehensive <i>in‑silico</i> molecular analysis of early‑onset gastric cancer identifies novel genes implicated in disease characterization and progression (Review)Fernán Gómez-Valenzuela, Ian Silva, Ignacio N Retamal, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Asian Pacific Journal of Cancer Prevention : APJCP|January 26, 2019
Prevalence of EGFR Mutations and Clinico-Pathological Characteristics of Chilean Lung Cancer PatientsRoger Gejman, Sergio González, Matías Muñoz-Medel, et al.
Frontiers in Oncology|May 29, 2024
<i>Porphyromonas gingivalis</i>, a bridge between oral health and immune evasion in gastric cancerMatías Muñoz-Medel, Mauricio P Pinto, Lauren Goralsky, et al.
International Journal of Molecular Sciences|December 16, 2020
The Reprimo-Like Gene Is an Epigenetic-Mediated Tumor Suppressor and a Candidate Biomarker for the Non-Invasive Detection of Gastric CancerMaría Alejandra Alarcón, Wilda Olivares, Miguel Córdova-Delgado, et al.
BJR Case Reports|April 4, 2025
Isocitrate dehydrogenase 1 gene mutations: a case review unveiling its biological impact on disease progression, prognosis and treatment in Chilean patientsTomás de Mayo Glasser, Benjamín García-Bloj, Juan A Godoy, et al.
Revista Medica De Chile|November 9, 2021
[Update on neuroendocrine tumors]Diego Carrillo, Matías Muñoz-Medel, Ignacio Retamal, et al.
International Journal of Molecular Sciences|January 8, 2023
Differentially Expressed Genes and Signaling Pathways Potentially Involved in Primary Resistance to Chemo-Immunotherapy in Advanced-Stage Gastric Cancer PatientsMauricio P Pinto, Matías Muñoz-Medel, Ignacio N Retamal, et al.
BMC Cancer|September 16, 2021
A case-control study of a combination of single nucleotide polymorphisms and clinical parameters to predict clinically relevant toxicity associated with fluoropyrimidine and platinum-based chemotherapy in gastric cancerMiguel Cordova-Delgado, María Loreto Bravo, Elisa Cumsille, et al.
JCO Global Oncology|April 24, 2020
Retrospective Analysis of Chilean and Mexican GI Stromal Tumor Registries: A Tale of Two Latin American RealitiesGermán Calderillo, Matías Muñoz-Medel, Edelmira Carbajal, et al.
Cancers|July 16, 2020
A Molecular Stratification of Chilean Gastric Cancer Patients with Potential Clinical ApplicabilityMauricio P Pinto, Miguel Córdova-Delgado, Ignacio N Retamal, et al.
Oncology Reports|June 20, 2025
Comprehensive <i>in‑silico</i> molecular analysis of early‑onset gastric cancer identifies novel genes implicated in disease characterization and progression (Review)Fernán Gómez-Valenzuela, Ian Silva, Ignacio N Retamal, et al.
Pageof 2